Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes

INTRODUCTION: This study helps to define the implications of breast cancer anti-estrogen resistance 3 (BCAR3) in breast cancer and extends the current understanding of its molecular mechanism of action. BCAR3 has been shown to promote cell proliferation, migration and attachment to extracellular mat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Breast Cancer Res
Hoofdauteurs: Guo, Jimin, Canaff, Lucie, Rajadurai, Charles Vincent, Fils-Aimé, Nadège, Tian, Jun, Dai, Meiou, Korah, Juliana, Villatoro, Manuel, Park, Morag, Ali, Suhad, Lebrun, Jean-Jacques
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2014
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4311507/
https://ncbi.nlm.nih.gov/pubmed/25499443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-014-0476-9
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items